Search

Your search keyword '"Gerds, A. T."' showing total 1,282 results

Search Constraints

Start Over You searched for: Author "Gerds, A. T." Remove constraint Author: "Gerds, A. T."
1,282 results on '"Gerds, A. T."'

Search Results

2. Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia.

4. Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis

6. Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results

7. A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia

10. Longitudinal Assessment of Transfusion Intensity in Patients With JAK Inhibitor–Naive or –Experienced Myelofibrosis Treated With Momelotinib

13. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study

14. ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial

17. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

18. An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML

19. Pattern of somatic mutation changes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes

21. Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib

22. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

25. Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study

27. The ABNL-MARRO 001 study: a phase 1–2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes

28. NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024

30. A geno-clinical decision model for the diagnosis of myelodysplastic syndromes

31. Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia

34. Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis

36. Comparison of outcomes of HCT in blast phase of BCR-ABL1− MPN with de novo AML and with AML following MDS

37. Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera

38. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

39. Survival following allogeneic transplant in patients with myelofibrosis

41. Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation

49. Reduced Intensity Versus Myeloablative Allogeneic Hematopoietic Cell Transplant for Chronic Myelomonocytic Leukemia: A Single Institution Experience

50. Neighborhood Socioeconomic Disadvantage and Distance from Treatment Center Do Not Impact Survival Outcomes of Patients with Non-Hodgkin's Lymphoma (NHL) and Multiple Myeloma (MM) Treated with CAR T-Cell Therapies.

Catalog

Books, media, physical & digital resources